Immunocastration Vaccine Research Articles

Improving Beef Cattle Production: Safety and Effectiveness of New Immunocastration Vaccine.

Reproductive control in mammals, particularly in beef production systems, is crucial for managing behaviors driven by sex steroids, which can cause biosecurity issues, reduced weight gain, and decreased meat quality. Additionally, controlling sexual activity in females prevents unwanted pregnancies when both sexes are housed together for fattening. Surgical castration in cattle, commonly performed under field conditions, is associated with significant welfare concerns due to pain and infection risks. Furthermore, castrating female cattle in the field is often impractically expensive. Hence, new reproductive control methods that prioritize animal welfare and are suitable for both sexes are essential. Immunocastration (IC), which involves vaccination against the GnRH-I hormone, has emerged as a promising alternative, demonstrating efficacy and safety in various species. Immunocastration has proven to be an effective alternative to surgical castration in controlling reproduction and promoting animal welfare in several species. This study aims to evaluate the safety, immunogenicity, immunocastration effect, and productive impact of a novel IC vaccine developed in Chile for female cattle. Two consecutive trials were conducted, the first under controlled conditions and the second under field conditions. The results demonstrated that the new vaccine is safe and effective for use in beef cattle, inducing specific immunity against GnRH-I, reducing gonadal functionality, and improving productive parameters. These findings suggest that this new IC vaccine can significantly benefit the beef cattle industry by providing a welfare-friendly and efficient method of reproductive control.

Active immunization with recombinant GnRH6-CRM197 inhibits reproductive function of male rats

Gonadotropin-releasing hormone (GnRH) vaccines have been successfully used for the inhibition of gonadal development and function, but current GnRH-based vaccines often present variability in the response. Cross-reactive material 197 (CRM197) has been used as carrier molecules to enhance an immune response to associated antigens. So, the synthetic mammalian tandem-repeated GnRH hexamer (GnRH6) gene was integrated into the expression plasmid pET-21a. Recombinant GnRH6-CRM197 protein was subsequently overexpressed in Escherichia coli strain BL21 and purified through Nickel column affinity chromatography and the antigenicity and biological effects of GnRH6-CRM197 were evaluated in rats. Sixteen 4-month-old adult male rats were randomly divided into two groups: the GnRH6-CRM197 group (n = 8) and the control group (n = 8). The GnRH6-CRM197 group rats were subcutaneously immunized with 100 μg of GnRH6-CRM197, administered thrice at 2-week intervals with GnRH6-CRM197.The control group received only a white oil adjuvant. Following the initial immunization, the weights of animals were recorded, and blood samples were collected from the orbital sinus at 4, 4.5, 5, 5.5, 6, 6.5, and 7 months. Serum antibody titers and testosterone concentrations were quantified using ELISA and CLIA, respectively. Additionally, testicular tissues were collected for morphological examination. The results revealed a significant increase in serum GnRH antibody titers (p < 0.05), but a significant decrease in serum testosterone concentrations (p < 0.05), and the weight, length, width, and girth of the testis, and the number of spermatogonia cells, spermatocytes, and sperm cells in the immunized rats. Furthermore, seminiferous tubules revealed significant atrophy and no sperm were observed in the immunized animals. Thus, GnRH6-CRM197 may be an effective antigen and a potential immunocastration vaccine.

Multiple-Pathway Synergy Alters Steroidogenesis and Spermatogenesis in Response to an Immunocastration Vaccine in Goat.

Animal reproduction performance is crucial in husbandry. Immunocastrated animals serve as an ideal animal model for studying testicular function. During androgen suppression, the testis undergoes dramatic developmental and structural changes, including the inhibition of hormone secretion and spermatogenesis. To characterize this process, we investigated the effects of castration using a recombinant B2L and KISS1 DNA vaccine, and then identified functional genes in the testes of Yiling goats using RNA-seq and WGS. The experimental animals were divided into three groups: the PVAX-asd group (control), PBK-asd-immunized group, and surgically castrated group. The results demonstrated that the administration of the recombinant PBK-asd vaccine in goats elicited a significant antibody response, and reduced serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH), resulting in smaller scrotal circumferences and decreased sexual desire compared to the control group. In addition, RNA transcriptome sequencing (RNA-seq) analysis of the testes revealed that the biological processes after immunocastration mainly focused on the regulation of cell matrix adhesion, histone acetylation, negative regulation of developmental processes, apoptosis, and activation of the complement system and the thrombin cascade reaction system. Then, we integrated the whole-genome sequencing and testis transcriptome, and identified several candidate genes (FGF9, FST, KIT, TH, TCP1, PLEKHA1, TMEM119, ESR1, TIPARP, LEP) that influence steroidogenesis secretion and spermatogenesis. Multiple pathways and polygenic co-expression participate in the response to castration vaccines, altering hormone secretion and spermatogenesis. Taken together, our atlas of the immunocastration goat testis provides multiple insights into the developmental changes and key factors accompanying androgen suppression, and thus may contribute to understanding the genetic mechanism of testis function. Joint analysis of whole genome sequencing and RNA-seq enables reliable screening of candidate genes, benefiting future genome-assisted breeding of goats.

Palmitic acid-modified GnRH-Th epitope peptide immunocastration vaccine (W/O/W adjuvant) can effectively ensure the castration and reduce the smelly smell in boars.

Recent studies have demonstrated the effectiveness of Gonadotropin-releasing hormone (GnRH) in inhibiting testicular growth and development in male animals to achieve castration while improving the meat quality of various livestock species, including cattle, sheep, goats, and pigs. In this research, a GnRH-Th vaccine was synthesized using the Fmoc solid-phase synthesis technique, and the T helper (Th) antigen was modified with palmitic acid to improve its efficacy. The vaccine was then coated with a water-in-oil-in-water adjuvant to improve stability and safety. After passing safety and stability tests, the vaccine was administered to 13-week-old boars. The results showed that it was stable, safe, and effective for up to 15 months. Moreover, the vaccine did not negatively affect the growth rate and body weight of the pigs. The palmitic acid-modified "GnRH-Th epitope peptide immunocastration vaccine (Water-in-Oil-in-Water (W/O/W)) effectively reduced the testosterone concentration and achieved castration. The concentration of androstenone and skatole hormones significantly decreased, leading to improved meat quality in the boars. The boars were then slaughtered at 33 weeks of age, and the results showed that the meat quality of the vaccinated boars was superior to that of the non-vaccinated control group (p < 0.05). This study demonstrated that GnRH can safely and effectively achieve immune castration in boars after coupling T cell epitopes, palmitic acid modification and W-O-W coating. Provide a better method for the further development of GnRH and the realization of animal welfare.

Delivering an Immunocastration Vaccine via a Novel Subcutaneous Implant.

Simple SummaryMale cattle (bulls) are often castrated as part of routine herd management. The benefits of this practice include the reduction of aggression and the elimination of unwanted pregnancies. However, castration represents an animal welfare concern as bulls are subjected to pain during and after the procedure. Surgical castration, in particular, places animals at increased risk of hemorrhage and infection. Immunocastration, a method involving vaccination against the hormones that regulate reproduction, offers a reduced-pain alternative to traditional castration, but the current products require multiple doses to effectively reduce fertility for extended periods. In an effort to improve upon current multi-dose immunocastration strategies, we evaluated the efficacy of a single-dose implantable immunocastration vaccine. This implant was designed to reduce fertility without the need for multiple doses, thus improving welfare for the animals as well as safety for producers and clinicians. The results presented here are promising and suggest that further refinement of the immunocastration implant could provide a convenient alternative to current immunocastration strategies.Immunocastration relies on the vaccine-mediated stimulation of an immune response to gonadotropin-releasing hormone (GnRH) in order to interrupt spermatogenesis. This approach offers a less painful alternative to traditional castration approaches but the current, commercially available options require multiple doses of vaccine to maintain sterility. Thus, a series of pilot studies were conducted to determine the feasibility of a single-dose immunocastration vaccine implant. These five studies utilized a total of 44 Holstein bulls to determine the optimal vaccine composition and validate the ability of a stainless-steel subcutaneous implant to deliver a vaccine. Outcome measures included the duration of implant retention, scrotal dimensions and temperature, implant site temperature, anti-GnRH antibodies, and serum testosterone concentration. Over the course of several studies, anti-GnRH antibodies were successfully stimulated by vaccine implants. No significant treatment effects on scrotal dimensions or testosterone were detected over time, but changes in spermatogenesis were detected across treatment groups. Results indicate that a single-dose implantable immunocastration vaccine elicits a humoral immune response and could impact spermatogenesis in bulls. These findings provide opportunities for the refinement of this technology to improve implant retention over longer periods of time. Taken together, this approach will offer producers and veterinarians an alternative to physical castration methods, to improve animal welfare during routine livestock management procedures.

Immunocastrated female pigs’ social and feeding behaviour

This study compared the social and feeding behaviour of immunocastrated female pigs using different immunocastration protocols. We used seventy-two gilts from industrial crossbreeding (Agroceres × Topigs) at 15 weeks of age. The pigs were distributed in a randomised design with three treatments. The second dose of the immunocastration vaccine was applied in two groups, six weeks before slaughter (I6) and four weeks before slaughter (I4). A non-immunised group (NI) was used for comparison. Due to the divergence in the [...]

Water intake and wastage during the growing–finishing period of immunocastrated and surgically castrated pigs

Context An adequate management of water use is essential in agricultural systems, including pig farming. Reducing the water footprint is important to preserve this natural resource, although there is limited qualitative information about water intake and water intake behaviour, especially in immunocastrated pigs. Aim The objective of this study was to compare water disappearance, and estimate wasted water and water intake behaviour for immunocastrated and surgically castrated male pigs. Methods Twenty-four surgically castrated male pigs and 24 entire male pigs submitted to immunocastration were used, with an average initial weight of 29.3 kg (±1.9 kg) and an age of 75 days. The pigs were housed in a growing–finishing facility with 24 pens and two animals per pen; each pen was equipped with a semi-automatic feeder and a bite-ball drinker with a water meter. The disappearance of water was measured by collecting the values of the water meters on a daily basis, and the water intake behaviour was determined by collecting the values of the water meters per hour. Water input and output values were estimated, and wasted water was calculated by subtracting the input from the output value. Key results The weekly average water disappearance for surgically castrated males was higher (P &lt; 0.05) than that for immunocastrated males, except in the last 2 weeks of the experimental period; the same was observed when expressed based on weight. Castrated animals also wasted 21.4% more water than immunocastrated animals. Regarding the water consumption profile, there were no differences between the two groups; water consumption was higher in the afternoon. The lower water disappearance in immunocastrated pigs was due to the increase in feed intake after the second dose of the immunocastration vaccine and to the lower amounts of waste because of less aggressive behaviour. Conclusion Immunocastrated male pigs have a smaller water footprint, but a similar water intake behaviour compared with surgically castrated animals. Implications Knowledge of the profile of water intake and a way to estimate water waste allows more efficient and sustainable management of water resources in pig production systems.

Reproductive status effects of pair-housed male pigs on natural, agonistic and sexual behaviours

Boar rearing, which avoids pain and suffering caused by surgical castration, provides better performance, a greater deposition of muscle tissue and leaner carcasses and thus has beneficial effects on both animal welfare and the product. Some countries that do not slaughter boars must consider their boar taint and aggressive and sexual behaviours. Considering that pigs are housed in large groups, which may complicate the formation of social hierarchies and increase fighting and mounting behaviours, some studies have conducted research with reduced numbers of pigs per pen, but these behaviours continued to be observed. However, a study of the reproductive status of pair-housed male pigs has yet to be reported. The aim of this study was to determine whether the reproductive status of uncastrated, immunocastrated and surgically castrated pair-housed male pigs alters their natural, agonistic and sexual behaviours. A total of 48 male pigs from Agroceres PIC™ genetics were assigned to three groups: surgically castrated (barrows), immunocastrated and uncastrated (boars). Natural, aggressive and sexual behaviours of the pigs were assessed by direct observations during four periods of 12 h each (six, five and three weeks before slaughter and the slaughter week). The pigs were housed in pairs from the growing phase until slaughter. Animal behaviour was observed from the finishing phase to slaughter. Carcass lesions were assessed according to five different classes (one: no injury; two to five: severely injured). Overall, boars spent more time lying and less time eating and drinking than barrows. In total of all the periods (48 h), boars expressed more aggressive and sexual behaviours than barrows, whereas immunocastrated pigs displayed similar behaviours to boars, before and after the second vaccine dose. No differences in carcass lesions between treatments and no prevalence of carcasses with severe injuries were observed. In conclusion, the reproductive status of pair-housed male pigs did not change the natural behaviour of boars, immunocastrated pigs or barrows. The agonistic and sexual behaviours of boars and barrows remained unchanged. When housing pigs in pairs, immunocastrated pigs presented similar agonistic and sexual behaviours to boars before and after the second immunocastration vaccine dose. The use of pair-housed uncastrated male pigs has generated welfare benefits for these animals, as the number of carcasses with injuries did not differ from barrows and immunocastrated pigs.

Welfare traits of Bos indicus cattle castrated immunologically and fed beta-adrenergic agonists.

ObjectiveThis work was carried out to evaluate the effects of zilpaterol hydrochloride (ZH) and ractopamine hydrochloride (RH) combined with immunocastration on the welfare traits of feedlot Nellore cattle.MethodsNinety-six Nellore males (average body weight [BW] = 409±50 kg; average 20 mo of age) were divided into two groups according to BW; half of the animals in each group received two doses of an immunocastration (ImC) vaccine in a 30 day interval, and the other half did not receive the vaccine (NoC). Afterward, the animals were housed and fed a common diet for 70 days. Then, they were split into three groups and fed one of the following diets for 30 additional days: control (CO) diet, with no β-AA; ZH diet, containing 80 mg/d ZH; and RH diet, containing 300 mg/d RH. Welfare traits were assessed by monitoring body surface temperature using infrared thermography (IRT) and plasma cortisol and temperament measurements.ResultsThere was no interaction between sexual condition and diet for any trait. The ImC and NoC groups did not differ in rectal and ocular temperatures. The ImC animals had higher flight speeds (p = 0.022) and tended to have higher cortisol levels (p = 0.059) than the NoC animals. Animals fed ZH and RH did not differ in cortisol levels, respiratory rate, rectal temperature, temperature measured by IRT, or temperament behaviour.ConclusionThe ImC animals showed a less stable temperament during handling practices than NoC, whereas ZH and RH supplementation had no adverse effects on animal welfare.

Effect of Kisspeptin-54 immunization on performance, carcass characteristics, meat quality and safety of Yiling goats

This study aimed to evaluate the effects of kisspeptin-54 immunocastration vaccine on performance, carcass characteristics, meat quality, and safety of Yiling goats. Thirty buck goats were randomly assigned into three groups: PVAX-B2L-Kisspeptin-54-asd immunized (PBK-asd), control, and surgically castrated. PBK-asd immunization significantly stimulated serum anti-kisspeptin antibody production and reduced testosterone hormone compared with the control group (p < .05). Interestingly, PBK-asd plasmid did not integrate into the host genome and had no significant effect on growth hormone, body weight, and average daily gain (ADG). Conversely, surgical castration significantly reduced ADG and carcass weight compared to the control group. Furthermore, PBK-asd immunization did not affect carcass characteristics (dressing percentage, loin area, and fat thickness) and meat quality traits (pH, color, cooking loss, drip loss, and shearing force). These results indicate that the Kisspeptin-54 DNA vaccine is safe and has potential to be used as an alternative to surgical castration for goats without negatively affecting carcass and meat quality.

Endurance Exercise Promotes Muscle Stem Cell Self-renewal and Repair Function in Adult Skeletal Muscle Through Inhibition of Mitochondrial Respiration

This study aimed to evaluate the effects of kisspeptin-54 immunocastration vaccine on performance, carcass characteristics, meat quality, and safety of Yiling goats. Thirty buck goats were randomly assigned into three groups: PVAX-B2L-Kisspeptin-54-asd immunized (PBK-asd), control, and surgically castrated. PBK-asd immunization significantly stimulated serum anti-kisspeptin antibody production and reduced testosterone hormone compared with the control group (p < .05). Interestingly, PBK-asd plasmid did not integrate into the host genome and had no significant effect on growth hormone, body weight, and average daily gain (ADG). Conversely, surgical castration significantly reduced ADG and carcass weight compared to the control group. Furthermore, PBK-asd immunization did not affect carcass characteristics (dressing percentage, loin area, and fat thickness) and meat quality traits (pH, color, cooking loss, drip loss, and shearing force). These results indicate that the Kisspeptin-54 DNA vaccine is safe and has potential to be used as an alternative to surgical castration for goats without negatively affecting carcass and meat quality.

Recombinant B2L and Kisspeptin-54 DNA Vaccine Induces Immunity Against Orf Virus and Inhibits Spermatogenesis In Rats

Orf is a highly contagious zoonotic disease of small ruminants caused by Parapoxvirus. Kisspeptin, encoded by the KISS1 gene with its cognate receptor GPR-54 is recognized as an upstream orchestrator in the hypothalamic-pituitary-gonadal axis. This study was designed to construct a DNA vaccine that produces a fused peptide composed of a major immunodominant protein of the orf virus (B2L) and kisspeptin-54, a neuropeptide with recognized roles in mammalian reproductive biology. The administration of this recombinant vaccine is shown to produce a significant antibody and cell-mediated immune response directed against B2L compared to the control group (p < 0.05). Furthermore, we found that rats inoculated with PBK-asd vaccine up-regulated antigen-mediated splenocyte proliferation and significantly raised antigen-specific tumor necrosis factor-alpha (TNFα-), interferon-gamma (IFN-ϒ) and interleukin (IL-2) compared to the control group (p < 0.05). This recombinant vaccine also stimulated antibody responses to kisspeptin and decreased serum luteinizing hormone and testosterone levels. Moreover, the current recombinant vaccine caused testicular atrophy and arrested spermatogenesis. It is concluded that this recombinant B2L and Kisspeptin-54 vaccine could be a promising approach for construction of bivalent orf virus and immunocastration vaccine. Furthermore, we concluded that the orf virus envelope protein (B2L) could be used as an immunomodulator for kisspeptin-54 to produce a strong antibody response.

Immunocastration and its effects on carcass and meat traits of male pigs

To compose the experiment, 160 male Topgen pigs - 80 surgically castrated (treatment 1) and 80 immunocastrated (treatment 2) - were randomly selected from a commercial swine farm at the moment of slaughter. Surgical castration was performed when the animals were seven days of age and immunocastration was performed by administering two doses (2 mL each) of immunocastration vaccine (analogue of GnRF linked to a carrier protein, development of anti-GnRF antibodies, 200 mg of a GnRF-protein conjugate/mL) when they were 104 and 132 days of age. Animals from both treatments were maintained in masonry stalls, where they received water and ad libitum diet (the same feed for both groups). The animals were slaughtered at 160 days of age, and the length and width of the testicles of immunocastrated animals were evaluated, along with the degree and number of carcass lesions, carcass traits and meat quality of both treatments. The means of these measurements were calculated and compared by Student´s t-test. For the immunocastrated treatment, Pearson´s correlation coefficients were also calculated for testicle length and width with backfat thickness. Approximately 80% of the immunocastrated animals had testicle widths of 11 cm or less. Immunocastrated animals showed higher degrees of lesions, pH (initial and 8 hours), hue, muscle depth and loin eye area and lower brightness, redness, chroma and backfat thickness than the surgically castrated animals. The correlation between testicle length and width with backfat thickness was inverse. Immunocastration can be an alternative to improve the proportion of lean meat (longissimus thoracis) instead of fat (backfat thickness) leading to better carcass and meat quality, since fat has become undesirable from a nutritional point of view in swine.

Influence of immunocastration vaccine administration interval on serum androgen concentrations and testis activity in ram lambs

The objective of this study was to establish whether different intervals between primary and secondary immunocastration vaccinations had similar effects on the production of C-19 steroid hormones and testis tissue functionality. Forty Dohne Merino rams (5.5 months old) were allocated to the respective treatment groups, which included no vaccination (R), and four (IC4), three (IC3) or two (IC2) weeks between the primary and secondary vaccination. Administration of the secondary vaccination to all immunocastrated lambs occurred four weeks prior to slaughter. Blood samples were collected weekly for eight weeks, and serum C-19 steroid metabolites were determined with ultra-performance convergence chromatography tandem mass spectrometry. Testes were collected at slaughter to assess size and level of tissue activity, as indicated by the cut surface CIE Lab colour measurement, seminiferous tubule circumference and seminiferous tubule epithelium thickness. Serum cortisol concentrations fluctuated but immunocastration had no influence. Serum testosterone concentrations decreased in IC4, IC3 and IC2 lambs between primary and secondary vaccinations, but consistently low testosterone concentrations (<0.5 ng/mL) were only observed a week after the secondary vaccination. Immunocastration resulted in a decrease in testis weight, seminiferous tubule circumference and tubule epithelium thickness across all vaccination treatments, which indicates impaired spermatogenesis. However, the most pronounced decrease in seminiferous tubule epithelium depth was observed in the testes of IC3 and IC2 lambs. The CIE colour a* values measured on the cut testis surface differed between vaccination intervals, indicating potential differences in the extent of interrupted activity. Therefore, the immunocastration vaccination interval of lambs is flexible, while still being successful in suppressing testosterone secretion and interrupting functioning of the testes.

Farklı Dozlarda İmmunokostrasyon Aşı Uygulamasının Entansif Koşullarda Yetiştirilen Holstein Erkek Danalarının Besi Performansı Üzerine Etkisi

The aim of the study is to determine the effect of immunocastration vaccine administration at different doses on fattening performance of feedlot Holstein bulls. In this research, 94 Holstein male calves assigned to the 4 treatments. Control group; 1 mL of 0.9% saline solution was subcutaneously injected to intact bulls on 1st and 60th days of the feedlot as placebo. On the same days of the feedlot, Immunocastration vaccine (Bopriva®) at two doses of 1 mL and 1 mL for Trial-1 group, 1.5 mL and 1.5 mL for Trial-2 group, 1.5 mL and 1 mL for Trial-3 group were subcutaneously injected to bulls. The feedlot lasted 180 days. Immunocastration vaccine administration at different doses did not affect the live weights (LWs) and cold carcass yields of feedlot Holstein bulls (P>0.05). However, it reduced fattening performance between 61-120 days (P<0.05) and 1-180 days (P<0.01). As a result, it was decreased the fattening performance that administration of Bopriva® at different doses as a GnRH vaccine in Holstein male bulls; whereas it was determined that numerically increase in average daily live weight gain was found in the Trial-2 group than the other groups to which the immunocastration vaccine was applied.

Effect of active immunization using a novel GnRH vaccine on reproductive function in rats

To investigate the effect of gonadotropin-releasing hormone 2-multiple antigen peptide (GnRH2-MAP) on reproductive function. In our study, 20-day-old male rats (n = 90) were randomly allocated to one of three treatment groups: GnRH2-MAP immunization, GnRH2 immunization, and non-immunized control groups. The immunized animals were administered three doses of GnRH2-MAP or GnRH2 vaccines from 0 to 6 weeks at 2-week intervals. The control group only received oil adjuvant. Blood and right testis samples were collected, and the left testis was weighed and its volume was measured at 0, 2, 4, 6, 8, 10 and 12 weeks after the first immunization. The serum antibody titer and testosterone concentration were determined by ELISA, and the right testis samples were collected for histological analysis. The results revealed that the serum of vaccinated rats elicited a significantly higher antibody titer and a lower T concentration compared with the control group two weeks after the first immunization (P < 0.05), but the highest antibody titer and lowest T concentration were found in animals treated with GnRH2-MAP (P < 0.05). The second immunization resulted in a significant decrease in testicular weight and volume (P < 0.05) in both immunized groups compared to the control, but these values were significantly lower in the GnRH2-MAP group than in the GnRH2 group. Furthermore, seminiferous tubules revealed more significant atrophy in the GnRH2-MAP group than in the GnRH2 group, and no sperm were observed in rats of the GnRH2-MAP group. Thus, GnRH2-MAP may be an effective antigen and a potential immunocastration vaccine with higher effectiveness.

The influence of vaccination interval on growth, carcass traits and testicle parameters of immunocastrated ram lambs

This study determined the effect of different immunocastration vaccine administration intervals on growth, carcass traits and testis development of ram lambs. The trial consisted of four treatment groups of 10 Dohne Merino rams per group. The trial was initiated when the rams were 5.5 months of age, with the control treatment being represented by intact (R) ram lambs. The treatments consisted of two (IC2), three (IC3) and four (IC4) week intervals between the primary and secondary vaccine administration and the total duration of the trial was 9 weeks. Slaughter age was fixed at 4 weeks post second vaccination for all treatment groups. Live body weight, scrotal circumference and temperature as well as injection reaction score and temperature were recorded weekly. At slaughter, the carcass and individual offal items were weighed, and shoulder circumference, neck circumference and subcutaneous backfat thickness measured 24h post-mortem. Vaccination interval was found to influence the average daily gain (ADG) between first and second vaccination; with this difference not observed when ADG was considered for the overall trial period. Vaccination schedule did not influence slaughter weight, carcass weight, subcutaneous backfat thickness, and linear carcass measurements. It was found that vaccination schedule had an effect on the percentage contribution of the gastrointestinal tract to total carcass weight, indicating a possible effect on gut fill. Differences in scrotal circumference between the immunocastrated groups and R were evident from week 4. From week 5, the scrotal circumferences of rams from the IC3 and IC2 treatment groups were smaller when compared to the control group, and remained smaller until the end of the trial. The immunocastration protocols followed in the study thus were successful in inhibiting testis growth and potentially function, without impacting negatively on the overall growth performance and slaughter performance of the ram lambs.

Metabolic modifiers as performance-enhancing technologies for livestock production

• Population growth and ever-increasing competition for land, food, water, and energy is forcing livestock industries to improve the efficiency with which they can produce their products. • Growth promoters, metabolic modifiers, and management strategies require constant development and research to ensure that these industries remain profitable. • As incomes increase in the burgeoning economies, so does the demand for high-quality animal proteins such as meat, milk, and eggs; thus, the Food and Agriculture Organization of the United Nations suggests that food requirements will increase by 70% by 2050 (Anonymous, 2009) • There are metabolic modifiers such as recombinant porcine somatotropin, dietary β-agonists, hormone growth promotants, and an immunocastration vaccine available for some livestock industries. However, there is mounting resistance from retailers and consumer groups who advocate that food should be produced naturally. • There is overwhelming evidence for the continued use and development of new growth-promoting technologies, but retailers and consumer groups as well as artificial trade barriers may yet prove to be too disruptive.

Effectiveness of an immunocastration vaccine formulation to reduce the gonadal function in female and male mice by Th1/Th2 immune response

Immunocastration has emerged as an alternative to surgical castration in different animal species. This study examined the effectiveness of a new vaccine formulation for immunocastration using the biopolymer chitosan as adjuvant. First, female and male mice (n = 4), in three subsequent experiments were vaccinated at Days 1 and 30 of the study, to determine the immune response profile and gonadal alterations due to immunization. The results demonstrated that the vaccine was able to elicit strong antibody responses against native GnRH hormone (P < 0.01), with a T helper (Th) 1/Th2 immune response profile. Along with this, a suppression of gonadal activity with a decrease of luteal bodies (1.08 ± 0.22 and 4.08 ± 0.39) and antral follicles (1.17 ± 0.32 and 4.5 ± 0.38) in the ovaries of immunized females and control, respectively, and a reduction of seminiferous tubules size (142.3 ± 5.58 mm and 198.0 ± 6.11 mm) and germinal cellular layers (3.58 ± 0.26 and 5.08 ± 0.29) of immunized males and control animals, respectively, were observed (P < 0.01). Then, in a study of long-term immune response due to vaccination in female and male mice (n = 4) from two subsequent experiments, a suppression of gonadal function and an induction of a Th1/Th2 immune response was also observed, determined by both, immunoglobulin and cytokine profiles, which lasted until the end of the study (7 months; P < 0.01). The findings of this study have demonstrated that vaccination with a new immunocastration vaccine inducing a Th1/Th2 immune response against GnRH (P < 0.01) elicit a decrease of gonadal function in male and female mice (P < 0.01). Owing to long-term duration of the antibody levels generated, this vaccine formulation appears as a promising alternative for immunocastration of several animal species where long-lasting reproductive block is needed.

Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice.

Relatively molecular mass of GnRH antigens is small and hence needs to couple to a large carrier molecule to enhance its immunogenicity. This study investigated whether hepatitis B surface antigen S (HBsAg-S) gene can be used as an effective carrier molecule for developing GnRH DNA immunocastration vaccine. Two copies of human GnRH gene were fused with HBsAg-S gene for constructing a recombinant plasmid pVAX-HBsAg-S-2GnRH that coded for 27kDa target fusion protein. Ten male mice were divided into two equal groups, treatment and control. The vaccine (50μg/mice) prepared in saline solution was injected into male mice at weeks 0, 1, 2, 4 and 7 of the experiment. Vaccine's efficacy was evaluated in terms of GnRH-specific IgG antibody response, plasma testosterone levels, testicular weight and extent of the testicular tissue damage. The specific anti-GnRH antibody titre in vaccinated animals was significantly higher than in controls in only 4th week of immunization (p<0.05). In addition, vaccinated animals showed lower testicular weight than those of the controls (p<0.05). Spermatogenesis in seminiferous tubules in vaccinated animals was suppressed. In conclusion, in this study, the engineered plasmid to be used as a GnRH DNA vaccine induced antibody response and suppressed spermatogenesis in mice. This suggests that HBsAg-S gene can be an effective carrier molecule for developing GnRH DNA immunocastration vaccine when relatively molecular mass of the aimed antigens is small.